Latest "Mifepristone Cushing Syndrome" News Stories

14:15 EDT 25th October 2014 | BioPortfolio

Here are the most relevant search results for "Mifepristone Cushing Syndrome" found in our extensive news archives from over 250 global news sources.

More Information about Mifepristone Cushing Syndrome on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Mifepristone Cushing Syndrome for you to read. Along with our medical data and news we also list Mifepristone Cushing Syndrome Clinical Trials, which are updated daily. BioPortfolio also has a large database of Mifepristone Cushing Syndrome Companies for you to search.

Showing "Mifepristone Cushing Syndrome" News Articles 1–25 of 2,200+

Extremely Relevant

NormoCort Could Become Leading Cushing’s Syndrome Drug, Says GlobalData

Cortendo’s NormoCort has the potential to become the front-line medical therapy for cushing’s syndrome (CS), but only if its commercial strategy adapts to a growing market

Cortendo Enrolls First Patient into Cushing’s Study

Cortendo AB announced that the first patient has been enrolled into the Phase 3 SONICS trial, i.e., “Study of NormoCort in Cushing’s Syndrome.” The patient was enrolled by one of the trial’s lead principal investigators at a Pituitary Center from a prestigious institution in Baltimore, Maryland.

Relevant

Serotonin transporter is a mifepristone pharmacological target

(Neural Regeneration Research) Results show that mifepristone attenuates serotonin transporter activity by directly inhibiting the serotonin transporter, and suggests that the serotonin transporter is a pharmacological target of mifepristone for the ...

Corcept shares halved on mifepristone failure in depression

Corcept Therapeutics saw its stock price cut in half after the company revealed in its first quarter earnings report that mifepristone failed to achieve the primary endpoint in a Phase III clinical trial for the treatment of psychotic depression.

Cushing disease: Often a victim of mistaken identity

The symptoms of Cushing disease are unmistakable to those who suffer from it -- excessive weight gain, acne, distinct colored stretch marks on the abdomen, thighs and armpits, and a lump, or fat deposit, on the back of the neck. Yet the disorder ofte...

Corcept falls on 1Q14 financial results, trial discontinuation

Corcept Therapeutics Inc. (NASDAQ:CORT) fell $2.03 (50%) to $1.99 on Wednesday after the company reported 1Q14 financial results that missed the Street and disclosed that it discontinued the Phase III Study 14 of mifepristone to treat psychotic depre...

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Sinai Hospital of Baltimore endocrinologist, Henry G. Fein, M.D., today presented new research showing that patients with Cushing's syndrome, a rare disease that can lead to extreme weight gain, type 2 diabetes, high blood pressure and psychological ...

New Research on Corcept's Korlym(R) for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014

CHICAGO, IL -- (Marketwired) -- 06/19/14 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders, today announced that new clinical research on Korlym® (mifepristone) will be presented at the joint meeting of the International Socie...

Cortendo enrols first patient in Phase 3 SONICS trial

Cortendo has announced that the first patient has been enrolled into the Phase 3 SONICS trial, i.e., “Study Of NormoCort In Cushing’s Syndrome."

/ CORRECTION - Corcept Therapeutics

CHICAGO, IL -- (Marketwired) -- 06/20/14 -- In the news release, "New Research on Corcept's Korlym® for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014," issued Thursday, June 19, 2014 by Corcept Therapeutics (NASDAQ: CORT), we are advised by the company that the session schedule has now been updated to reflect accurate presentation times with poster numbers added. Complete cor...

Mifepristone: Phase III discontinued

Genetics: Pinpointing a hotspot in adrenal Cushing syndrome

A gain-of-function point mutation in the gene that encodes one of the catalytic subunits of protein kinase A (PRKACA) in cortisol-producing adrenocortical adenomas has been independently reported by three groups. This hotspot point mutation (c.617T>G...

Gilberts Syndrome

Gilbert’s syndrome is a common, harmless condition that can run in families. People with this syndrome sometimes get jaundice when they are under stress, take certain medicines, or have an infection. Women with Gilbert’s syndrome might get jaundi...

High prevalence of ophthalmic disorders in Down's syndrome

Jensen and Bulova’s otherwise excellent review of the care of adults with Down’s syndrome did not mention the ocular manifestations of Down’s syndrome, which are common and can seriously reduce...

Rett Syndrome Association of MA joins Rettsyndrome.org to explore treatment option

(International Rett Syndrome Foundation) Rett Syndrome Association of Massachusetts and Rettsyndrome.org are thrilled to announce today their renewed commitment to work together to defeat Rett syndrome. A generous $150,000 donation from RSAM will sup...

Medical News Today: Down syndrome: what is the current focus of research?

In our follow-up to yesterday's Down Syndrome Awareness Month spotlight feature, we talk to some of the leading experts in Down syndrome research.

Rheumatoid arthritis and metabolic syndrome

Rheumatoid arthritis (RA) and metabolic syndrome share several pathologic characteristics, such as changes in body composition, lipid levels and insulin sensitivity, that may increase cardiovascular mortality. Here, Kerekes and co-authors discuss ass...

Basketball Star's Career Cut Short by Diagnosis of Marfan's Syndrome

Individuals with Marfan's Syndrome (see: Marfan syndrome) are often very tall so I have wondered whether some basketball players have this genetic disorder. A recent article cited a specific instance of this (see: Baylor star Isaiah Austin's NBA pros...

High risk for congenital heart defects in Down syndrome provides tool to identify changes in genes

Down syndrome is the most common chromosomal abnormality in humans, involving a third copy of all or part of chromosome 21. In addition to intellectual disability, individuals with Down syndrome have a high risk of congenital heart defects. However, ...

Down Syndrome: What Is the Current Focus of Research?

(Medical News Today) – Yesterday, as part of Down Syndrome Awareness Month, we looked at some of the controversial issues and popular perceptions surrounding pregnancy and Down syndrome. Now, in a follow-up feature, we speak to scientists and o...

Managing the care of adults with Down's syndrome

Summary pointsPeople with Down’s syndrome have experienced a dramatic increase in life expectancy, which is now in their mid-50sThe approach to primary care for adults with Down’s syndrome is similar...

Down syndrome: Behind the scenes of genetics, leukemia

A group of geneticists have focused for many years on the genetic characteristics of Down syndrome. They have sequenced the exome, a specific part of our genome, in a cohort of patients affected both by Down Syndrome and acute lymphoblastic leukaemia...

Heartbeat Client Korlym Named Brand of the Year by Pharmaceutical Executive

Pharmaceutical Executive magazine has selected Corcept Therapeutics’ Korlym® as the 2014 Brand of the Year. For the first time, the publication has recognized two brands in two distinct categories – one in the treatment of chronic disease and one in the treatment of orphan status rare disease. Teva Pharmaceutical’s Copaxone® was the Brand of the Ye...

Obesity: Cerebral damage in obesity-associated metabolic syndrome

The prevalence of the metabolic syndrome has increased in tandem with that of obesity. The metabolic syndrome is associated with structural and functional cerebral damage. A new study confirms the association between the metabolic syndrome and reduce...

GIST With Nephrotic Syndrome as a Paraneoplastic Syndrome

This unusual case documents a patient with GIST of the stomach who presented with refractory nephrotic syndrome. Journal of Medical Case Reports


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks